http://www.physorg.com/ en-us Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine. Four risk factors that help predict how long men may survive with metastatic prostate cancer could help doctors choose more effective treatments, according to a study led by researchers in the Duke Comprehensive Cancer Center. http://www.physorg.com/news161546633.html Medicine & Health Thu, 14 May 2009 19:04:16 EST news161546633 A new gene test may help predict which colon cancer patients are at higher or lower risk of having their cancer return after surgery, doctors report, but whether it is useful enough to justify its likely high price remains to be seen. http://www.physorg.com/news161544138.html Medicine & Health Thu, 14 May 2009 18:22:49 EST news161544138 (PhysOrg.com) -- As part of an effort to make high-precision particle cancer therapy accessible to more patients, a physicist at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory has developed a simpler, less-expensive gantry design for delivering tumor-killing particle beams. Brookhaven Science Associates, the company that manages the Lab for DOE, has applied for a U.S. non-provisional patent on the design, which is now available for licensing and commercial development. http://www.physorg.com/news161343117.html Medicine & Health Tue, 12 May 2009 10:33:17 EST news161343117 For men younger than 50 with prostate cancer, undergoing a radical prostatectomy can greatly increase their chances for long-term survival, according to a new study from Henry Ford Hospital. http://www.physorg.com/news161256606.html Medicine & Health Mon, 11 May 2009 10:30:30 EST news161256606 Cancer vaccines and targeted therapies are beginning to offer new treatment options following surgery for patients with early stages of lung cancer, experts said at the first European Multidisciplinary Conference in Thoracic Oncology (EMCTO) in Lugano, Switzerland (1-3 May 2009). http://www.physorg.com/news160593252.html Medicine & Health Sun, 03 May 2009 18:14:59 EST news160593252 Sipuleucel-T (Provenge), an experimental immunotherapy improved survival in men with metastatic disease, according to new results to be presented April 28 at the American Urological Association (AUA) Annual Scientific Meeting in Chicago. These data from the Phase 3 Immunotherapy for Prostate AdenoCarcinoma Treatment (IMPACT) study were presented during the meeting's Late Breaking Science Forum. http://www.physorg.com/news160215115.html Medicine & Health Wed, 29 Apr 2009 09:12:44 EST news160215115 Beyond lowering cholesterol, statin medications have been found to have numerous other health benefits, including lowering a healthy man's risk of developing advanced prostate cancer, as well as lowering his prostate-specific antigen (PSA) levels. http://www.physorg.com/news160152304.html Medicine & Health Tue, 28 Apr 2009 15:45:41 EST news160152304 Prostate cancer patients who undergo therapy to decrease testosterone levels increase their risk of developing bone- and heart-related side effects compared to patients who do not take these medications, according to a new analysis. Published in the June 1, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that preventive measures and careful scrutiny of patients' health can keep men from experiencing these potentially serious consequences. http://www.physorg.com/news160030200.html Medicine & Health Mon, 27 Apr 2009 05:50:31 EST news160030200 Although the presenting features of colorectal cancer are well known, the risks they confer are less well defined. New research published in the open access journal BMC Medicine describes the exact risks posed by eight clinical features for the development of colorectal cancer in a large group of patients. http://www.physorg.com/news159169660.html Medicine & Health Fri, 17 Apr 2009 06:48:37 EST news159169660 Gastroenterologists at Rush University Medical Center are studying the safety and efficacy of a new system for delivering chemotherapy for patients with esophageal cancer, a rare, but deadly disease that attacks the throat. The unique drug therapy delivers a highly concentrated dose of chemotherapy injected directly on to the hard-to-reach tumors in the esophagus non-surgically. Researchers at Rush are trying to determine if the gel treatment can reduce the size of the cancerous tumors. http://www.physorg.com/news159031314.html Medicine & Health Wed, 15 Apr 2009 16:22:25 EST news159031314 A study in the April 15 issue of the Journal of Clinical Sleep Medicine suggests that sleep problems lead to increased pain and fatigue in cancer patients. The results indicate that interventions aimed at trouble sleeping would be expected to improve both pain and fatigue in this patient population. http://www.physorg.com/news158992653.html Medicine & Health Wed, 15 Apr 2009 05:38:41 EST news158992653 Black patients suffering from lung cancer are less likely to receive recommended chemotherapy and surgery than white lung cancer patients, a disparity that shows no signs of lessening. That is the conclusion of a new study published in the May 15, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society. The study's findings indicate that efforts are needed to provide appropriate treatments for black patients and to educate them about the value of those treatments. http://www.physorg.com/news158835141.html Medicine & Health Mon, 13 Apr 2009 09:52:50 EST news158835141 Despite enduring more invasive tests and medical procedures, patients who were treated aggressively for early stage bladder cancer had no better survival than patients who were treated less aggressively. Further, the aggressively treated patients were more likely to undergo major surgery to have their bladder removed, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center. http://www.physorg.com/news158345682.html Medicine & Health Tue, 07 Apr 2009 17:55:21 EST news158345682 Cancer and its therapies, including chemotherapy and radiotherapy, may directly alter and damage taste and odor perception, possibly leading to patient malnutrition, and in severe cases, significant morbidity, according to a Virginia Tech - Wake Forest University Comprehensive Cancer Center compilation of various existing studies. Their review appears in the March/April 2009 Journal of Supportive Oncology. http://www.physorg.com/news157738322.html Medicine & Health Tue, 31 Mar 2009 17:12:22 EST news157738322 New data and analyses from a long-running study of cancer survival in Europe have shown that the number of people actually cured of cancer - rather than just surviving for at least five years after diagnosis - is rising steadily. http://www.physorg.com/news157098411.html Medicine & Health Tue, 24 Mar 2009 07:27:36 EST news157098411 Breast cancer patients with lymphedema in their upper arm experienced reduced fluid in the swollen arm by up to 39 percent after undergoing a super-microsurgical technique known as lymphaticovenular bypass, report researchers at The University of Texas M. D. Anderson Cancer Center. http://www.physorg.com/news157040271.html Medicine & Health Mon, 23 Mar 2009 15:21:17 EST news157040271 In a new study of terminally ill cancer patients, researchers at Dana-Farber Cancer Institute found that those who draw on religion to cope with their illness are more likely to receive intensive, life-prolonging medical care as death approaches -- treatment that often entails a lower quality of life in patients' final days. http://www.physorg.com/news156528099.html Medicine & Health Tue, 17 Mar 2009 17:04:38 EST news156528099 (PhysOrg.com) -- The combined expression of three specific genes in lung cancer tumors may predict both cancer growth and a poorer prognosis, according to a study led by researchers in the Duke Institute for Genome Sciences & Policy and the Duke Comprehensive Cancer Center. http://www.physorg.com/news155844873.html Medicine & Health Mon, 09 Mar 2009 19:15:21 EST news155844873 Countless people have heard the phrase, "You have lung cancer," but only 50 can say they've completed a new treatment at Temple University that doubles their chances of surviving the deadly disease - and without the conventional radiation regimen or surgery. Doctors in the Radiation Oncology Department say the technique, stereotactic body radiotherapy, or SBRT, not only improves a person's odds of surviving early stage lung cancer, but may reduce the need for future surgeries. http://www.physorg.com/news155403104.html Medicine & Health Wed, 04 Mar 2009 15:33:39 EST news155403104 Breast cancer patients 35 years old and younger have higher rates of their cancer returning after treatment than older women patients with the same stage of cancer, and their risk of recurrence is greatly impacted by the type of treatment they received, according to a March 1 study in the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO). http://www.physorg.com/news155397867.html Medicine & Health Wed, 04 Mar 2009 14:04:56 EST news155397867 A study by researchers at the University of California, San Francisco has shown that hypertension, or high blood pressure, is a predictor of mortality among breast cancer patients, especially those who are African-American, and that hypertension accounts for approximately 30 percent of the survival disparity between African-American and white breast cancer patients. http://www.physorg.com/news155396954.html Medicine & Health Wed, 04 Mar 2009 13:49:34 EST news155396954 When it comes to solving complex problems, Geoffrey von Maltzahn, MIT graduate student and biomedical engineer, looks to nature for solutions. Finding inspiration in systems that evolution has produced, von Maltzahn is currently helping to tackle one of society's biggest challenges: improving tumor detection and therapeutic delivery in order to boost the survival rate of cancer patients. http://www.physorg.com/news155294735.html Nanotechnology Tue, 03 Mar 2009 09:25:59 EST news155294735 A new generation of cancer drugs designed to starve tumors of their blood supply - called "angiogenesis inhibitors"--succeeds at first, but then promotes more invasive cancer growth -sometimes with a higher incidence of metastases, according to a new study in animals. The research clarifies similar findings in other animal studies and is consistent with some early evidence from a small number of clinical trials with cancer patients. http://www.physorg.com/news155226687.html Medicine & Health Mon, 02 Mar 2009 14:31:54 EST news155226687 The powerful chemotherapy and radiation used to save cancer patients' lives can also destroy their fertility. http://www.physorg.com/news154879664.html Medicine & Health Thu, 26 Feb 2009 14:08:07 EST news154879664 (PhysOrg.com) -- The anxiety of cancer returning is often overlooked by both patients and medics, according to leading experts in the disease. http://www.physorg.com/news154714235.html Medicine & Health Tue, 24 Feb 2009 16:11:10 EST news154714235 Metastatic esophageal squamous cell cancer has very poor prognosis. Conventional surgery is considered the most effective treatment, but many cases are inoperable at the time of diagnosis. http://www.physorg.com/news154620008.html Medicine & Health Mon, 23 Feb 2009 14:01:07 EST news154620008 Men who develop prostate cancer face an increased risk of having an aggressive tumor if they carry a so-called breast cancer gene mutation, scientists from the Albert Einstein College of Medicine of Yeshiva University report in today's issue of Clinical Cancer Research. The findings could help to guide prostate-cancer patients and their physicians in choosing treatment options. http://www.physorg.com/news152470146.html Medicine & Health Thu, 29 Jan 2009 16:49:48 EST news152470146 A preventive procedure to remove the unaffected breast in breast cancer patients with disease in one breast may only be necessary in patients who have high-risk features as assessed by examining the patient's medical history and pathology of the breast cancer, according to researchers at The University of Texas M. D. Anderson Cancer Center. http://www.physorg.com/news152162632.html Medicine & Health Mon, 26 Jan 2009 03:24:10 EST news152162632 Variations in mismatch repair genes can help predict treatment response and prognosis in patients with pancreatic cancer, according to research from The University of Texas M. D. Anderson Cancer Center presented today in advance of the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium. http://www.physorg.com/news151141502.html Medicine & Health Wed, 14 Jan 2009 07:45:02 EST news151141502 In a first of its kind study, a first-degree family history of prostate cancer has no impact on the treatment outcomes of prostate cancer patients treated with brachytherapy (also called seed implants), and patients with this type of family history have clinical and pathologic characteristics similar to men with no family history at all, according to a January 1 study in the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology. http://www.physorg.com/news150115064.html Medicine & Health Fri, 02 Jan 2009 10:37:44 EST news150115064